Drawing for PHARMA&

USPTO serial 97661425

PHARMA&

Reviewed by CopyMark Law Group

Reg. 7266524Status 700Registered
Filing date
Status date
Registration date
Jan 9, 2024
Examiner
RADEMACHER, APRIL LUEDERS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMA&?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew A. Homyk

Matthew A. Homyk BLANK ROME LLPONE LOGAN SQUAREPHILADELPHIA, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medications for the treatment of mental health; Medicines for the treatment of ulcerative colitis; Medicines for the treatment of Crohn's disease;ers; Medicines for the treatment of overactive-bladder syndrome; Medicines for the treatment of acute bronchial asthma attacks and reversible bronchospastic states associated with chronic bronchitis or emphysema; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations and substances for the treatment of hepatitis; Cardiovascular chemical-pharmaceutical treatment preparations; pharmaceutical preparations for use in urology; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of urological, cardiovascular, central nervous system, gastroenterological, pneumological, and hematological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations, namely, antiviralsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2023FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 15, 2023ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2023DOCKASSIGNED TO EXAMINER—
Jan 23, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 23, 2023ALIEASSIGNED TO LIE—
Nov 22, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 12, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 12, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 12, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 12, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 12, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 7, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance